We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00240747
Recruitment Status : Terminated
First Posted : October 18, 2005
Last Update Posted : May 25, 2012
Sponsor:
Collaborator:
Aventis Pharmaceuticals
Information provided by:
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Primary Completion Date : No date given
Study Completion Date : January 2005